Foreign Pharma Firms

With the pharma sector being rerated, given steady growth prospects and attractive valuations, all the companies, including pharma MNCs, will see greater investor interest

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

International drugmakers target lower-income patients